Pfizer Investigational Site — Hickory, North Carolina

Pfizer Investigational Site is a clinical research site located in Hickory, North Carolina, United States 28602.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

Pfizer Investigational Site has participated in 24 clinical trials.

Therapeutic areas: Breast Neoplasms, Neoplasms, Small Cell Lung Carcinoma.

Sponsors: Pfizer, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Wyeth is now a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Hickory

Browse all research sites in North Carolina · View every site in Hickory

• Catawba Memorial Hospital
• PMG Research of Hickory
• Research Site
• GSK Investigational Site
• Clinical Trials of America
• Graystone Eye
• Novartis Investigative Site
• Local Institution
• Unifour Medical Research Associates
• Accellacare Hickory
• Clinical Research Site

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pfizer Investigational Site?

Pfizer Investigational Site has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pfizer Investigational Site conducted?

Pfizer Investigational Site has 24 clinical trials on record. Their work covers Breast Neoplasms, Neoplasms, Small Cell Lung Carcinoma.

Is Pfizer Investigational Site accredited by Crixeo Clinical Trials?

Pfizer Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pfizer Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.